Pharmaceutical Executive: May 2023

From Science to Strategy | 2023 Emerging Pharma Leader

May 11, 2023

Executive Profile

43

5

How the pivot to corporate development became a natural fit for the once-destined scientist. (The story of Natasha A. Hernday, chief business officer of Seagen and a 2023 Emerging Pharma Leader.)

Committed to the Cause | 2023 Emerging Pharma Leader

May 11, 2023

Executive Profile

43

5

Driving commercial growth and patient access and empowerment in women’s health. (The story of Simon Holland, vice president, women's health commercial lead, for Organon and a 2023 Emerging Pharma Leader.)

A Knack for Problem-Solving | 2023 Emerging Pharma Leader

May 11, 2023

Executive Profile

43

5

The recipe for cross-functional collaboration in drug development. (The story of Justin To, chief operating officer, skeletal dysplasias and gene therapy, for Bridge Bio and a 2023 Emerging Pharma Leader.)

Rejuvenating Lives | 2023 Emerging Pharma Leader

May 11, 2023

Executive Profile

43

5

Scientist-turned-entrepreneur steers efforts to transform approaches in tissue regeneration. (The story of Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics and a 2023 Emerging Pharma Leader.)

A New Era for Market Access: Organizing the Function’s Broader Strategic Role

May 10, 2023

Feature

43

5

BCG’s 2022 benchmark study uncovers new competencies needed for pharma access leaders in enterprise-wide business strategy, where thoughtfully designed approaches and goals focused on shared priority and responsibility are increasingly important.

Rise and Recognition

May 07, 2023

From the Editor

43

5

This year marks my first involvement in Pharmaceutical Executive’s Emerging Pharma Leaders (EPL) Awards, and what a ride it has been. We received so many wonderful nominations, and it’s always humbling to learn about some of the intricacies of the research that’s being done as well as the accomplishments of both current leaders and up-and-coming leaders.